» Articles » PMID: 39257440

A Pan-cancer Analysis Of Wnt Family Member 7B in Human Cancers

Overview
Journal Cancer Innov
Date 2024 Sep 11
PMID 39257440
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies have highlighted the crucial role of in the development of various cancers, including breast, pancreatic, and gastric cancers. However, research into the involvement of is often confined to specific tumor types, with a noticeable lack of comprehensive studies spanning multiple cancer forms. The potential of as a diagnostic or prognostic cancer biomarker has not been fully explored.

Methods: In this study, we combined bioinformatics and immunohistochemistry analyses to examine the expression patterns and functions of in cancerous and adjacent noncancerous tissues across a range of tumors.

Results: Our data indicate that may serve as a novel prognostic biomarker and therapeutic target in certain cancers.

Conclusion: We found significant upregulation of expression levels in the majority of cancer cases examined. Furthermore, can influence cancer prognosis by modulating the tumor microenvironment, immune cell infiltration, and tumor stemness, among other factors. Additionally, we examined the associations between anticancer drug sensitivity and expression, which could aid in the development of more precise clinical therapies.

References
1.
Huang T, Fu L . The immune landscape of esophageal cancer. Cancer Commun (Lond). 2019; 39(1):79. PMC: 6878621. DOI: 10.1186/s40880-019-0427-z. View

2.
Gabrielson A, Wu Y, Wang H, Jiang J, Kallakury B, Gatalica Z . Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC. Cancer Immunol Res. 2016; 4(5):419-30. PMC: 5303359. DOI: 10.1158/2326-6066.CIR-15-0110. View

3.
Jiang S, Li Q, Liu Y, Zhang H, Wang Q, Chen Y . Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis. BMC Cancer. 2021; 21(1):180. PMC: 7893751. DOI: 10.1186/s12885-021-07898-2. View

4.
Tang C, Wang X, Ji C, Zheng W, Yu Y, Deng X . The Role of miR-640: A Potential Suppressor in Breast Cancer Wnt7b/β-catenin Signaling Pathway. Front Oncol. 2021; 11:645682. PMC: 8072343. DOI: 10.3389/fonc.2021.645682. View

5.
Yi M, Tan Y, Wang L, Cai J, Li X, Zeng Z . TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cell Mol Life Sci. 2020; 77(21):4325-4346. PMC: 7588389. DOI: 10.1007/s00018-020-03539-2. View